Susquehanna International Group
MNOV icon

Susquehanna International Group’s MediciNova MNOV Stock Holding History

Susquehanna International Group’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,100
Closed -$50K – 13601
2021
Q3 		$50K Sell
13,100
-40,400
-76% -$154K ﹤0.01% 12347
2021
Q2 		$227K Sell
53,500
-14,600
-21% -$62.9K ﹤0.01% 11319
2021
Q1 		$344K Buy
68,100
+24,000
+54% +$140K ﹤0.01% 10328
2020
Q4 		$232K Sell
44,100
-21,200
-32% -$121K ﹤0.01% 9790
2020
Q3 		$342K Buy
+65,300
New +$377K ﹤0.01% 8443
2017
Q2 		– Sell
-40,000
Closed -$240K – 9574
2017
Q1 		$240K Sell
40,000
-18,400
-32% -$111K ﹤0.01% 7735
2016
Q4 		$352K Buy
+58,400
New +$411K ﹤0.01% 7665

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group's MNOV Position: Q1 2026 in Review

Susquehanna International Group increased its MediciNova (MNOV) stake by 93% in Q1 2026, buying an estimated $32.1K and bringing the position to 43,926 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12580.

Susquehanna International Group first reported a position in MNOV in Q1 2016 and has held it in 27 quarters since. The position peaked at $771K in Q1 2016. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • Susquehanna International Group held 43,926 shares of MediciNova worth $60.2K as of Q1 2026.
  • Susquehanna International Group bought 21,173 MediciNova shares in Q1 2026, an estimated $32.1K.
  • MediciNova made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12580 holding.
  • Susquehanna International Group first reported a position in MediciNova in Q1 2016 and has held it in 27 quarters since.
  • Susquehanna International Group's MediciNova position peaked at $771K in Q1 2016.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.